Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07808073 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Name: A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy — clinical trial record (NCT07808073)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-09

View on ClinicalTrials.gov ↗

The main purpose of this study is to assess how well LY4329090 is tolerated and what side effects may occur in healthy participants with obesity or overweight. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Study participants will be in one of 2 parts. For each participant in Part A, the study will last about 10 weeks and will include a stay in the Clinical Research Unit (CRU) lasting 5 nights along with 5 outpatient visits to the CRU. For each participant in Part B, the study will last about 21 weeks and will include 4 stays totaling 11 nights along with 14 outpatient visits to the CRU.

Trial Details

NCT Number	NCT07808073
Lead Sponsor	Eli Lilly and Company
Conditions	Obesity, Overweight
Enrollment	184 participants
Start Date	2026-09
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-09-08